Skip to content
10-Q

Quarterly Report

Zura Bio Ltd ZURA

0001628280-26-031696

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 95M sh
Shares Diluted Q1 2026 · Mar 31, 2026 112.22M sh
Shares Diluted Q1 2026 · Mar 31, 2025 92.96M sh
Capex Q1 2026 · Mar 31, 2026 $13K
Capex Q1 2026 · Mar 31, 2025 $49K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$18.92M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$11.06M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $225.59M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $109.41M
Current Liabilities Q1 2026 · Mar 31, 2026 $11.75M
Current Liabilities Q1 2026 · Dec 31, 2025 $12.41M
Total Liabilities Q1 2026 · Mar 31, 2026 $11.75M
Total Liabilities Q1 2026 · Dec 31, 2025 $12.41M
Current Assets Q1 2026 · Mar 31, 2026 $227M
Current Assets Q1 2026 · Dec 31, 2025 $112.31M
Total Assets Q1 2026 · Mar 31, 2026 $228.64M
Total Assets Q1 2026 · Dec 31, 2025 $113.95M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.22
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.19
Eps Basic Q1 2026 · Mar 31, 2026 −$0.22
Eps Basic Q1 2026 · Mar 31, 2025 −$0.19
Sga Expense Q1 2026 · Mar 31, 2026 $10.75M
Sga Expense Q1 2026 · Mar 31, 2025 $8.78M
Rd Expense Q1 2026 · Mar 31, 2026 $14.75M
Rd Expense Q1 2026 · Mar 31, 2025 $10.47M
Net Income Q1 2026 · Mar 31, 2026 −$24.22M
Net Income Q1 2026 · Mar 31, 2025 −$17.44M
Operating Income Q1 2026 · Mar 31, 2026 −$25.5M
Operating Income Q1 2026 · Mar 31, 2025 −$19.25M